Provepharm is an independent, international pharmaceuticals specialties company that leverages the potential of well-known molecules to develop innovative solutions that meet critical unmet hospital needs and help improve patients’ lives.
It develops, manufactures and markets a range of products including antidotes and endoscopic and surgical dyes. Provepharm works closely with healthcare professionals and is committed to developing specific services to help them improve clinical practices.
With a team of over 160 employees in offices in France, the USA and the UK, the company distributes its products in over 25 countries worldwide and devotes between 20% and 25% of its revenues to R&D.
Provepharm strives daily to have a positive and significant social, societal and environmental impact in the performance of its activities: this is its purpose. In November 2023, it joined the very select club of pioneering pharmaceutical companies to be certified B Corp.
